<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//alveus-v2.innovatiemedia.nl/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/alveus-therapeutics-announces-second-and-final-closing-of-oversubscribed-series-a-bringing-total-financing-to-197-million-to-advance-next-generation-therapies-for-obesity-and-metabolic-diseases/</loc>
		<lastmod>2026-07-03T11:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/han-forlod-novo-for-at-bygge-nyt-fedmeselskab-op-fra-bunden-i-sidste-ende-foles-det-helt-rigtigt/</loc>
		<lastmod>2026-07-03T11:33:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/alveus-best-in-class-opportunity-in-obesity/</loc>
		<lastmod>2026-07-03T10:59:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/obesity-company-closes-capital-raising-of-dkk-1-2-billion-brings-novo-holdings-on-board/</loc>
		<lastmod>2026-07-03T11:05:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/alveus-therapeutics-announces-second-and-final-closing-of-oversubscribed-series-a-bringing-total-financing-to-197-million-to-advance-next-generation-therapies-for-obesity-and-metabolic-disea/</loc>
		<lastmod>2026-07-03T11:38:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/160-million-series-a-round-for-alveus/</loc>
		<lastmod>2026-07-03T11:07:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/alveus-therapeutics-exits-stealth-with-160m-developing-an-alternative-to-drugs-like-ozempic/</loc>
		<lastmod>2026-07-03T11:08:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/alveus-launches-with-160m-as-newest-start-up-to-step-into-obesity-fray/</loc>
		<lastmod>2026-07-03T11:09:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/obesity-biotech-alveus-gains-160m-for-push-into-maritides-backyard-and-amylins/</loc>
		<lastmod>2026-07-03T11:10:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/parabilis-heads-biotech-fundraising-frenzy-with-305m-to-advance-cancer-drug/</loc>
		<lastmod>2026-07-03T11:11:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/equipped-with-160m-series-a-alveus-debuts-into-crowded-obesity-development-landscape/</loc>
		<lastmod>2026-07-03T11:12:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/alveus-therapeutics-a-philadelphia-start-up-treating-obesity-debuted-with-160m-in-funding/</loc>
		<lastmod>2026-07-03T11:28:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/philadelphia-vc-firm-creates-obesity-drug-startup-raises-159-8m-series-a/</loc>
		<lastmod>2026-07-03T11:29:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/alveus-raises-160m-series-a-for-obesity-drugs/</loc>
		<lastmod>2026-07-03T11:30:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/biotech-alveus-raises-160-million-to-tackle-weight-loss-maintenance/</loc>
		<lastmod>2026-07-03T11:31:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/alveus-therapeutics-announces-fda-clearance-of-ind-and-first-patient-dosed-in-phase-1b-trial-of-alv-100-for-obesity/</loc>
		<lastmod>2026-07-03T11:42:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://alveus-v2.innovatiemedia.nl/alveus-therapeutics-launches-with-160-million-series-a-financing-to-advance-next-generation-therapies-for-obesity-and-metabolic-diseases/</loc>
		<lastmod>2026-07-03T11:43:40+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Rank Math SEO Plugin (c) Rank Math - rankmath.com -->